0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Disease Control and Prevention Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-10N7023
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Disease Control and Prevention Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Disease Control and Prevention Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-10N7023
Report
September 2024
Pages:168
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Disease Control and Prevention Vaccine - Market Size

The global market for Disease Control and Prevention Vaccine was estimated to be worth US$ 41900 million in 2023 and is forecast to a readjusted size of US$ 84190 million by 2030 with a CAGR of 10.4% during the forecast period 2024-2030

Disease Control and Prevention Vaccine - Market

Disease Control and Prevention Vaccine - Market

Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Disease Control and Prevention Vaccine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Disease Control and Prevention Vaccine by region & country, by Type, and by Application.
The Disease Control and Prevention Vaccine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Disease Control and Prevention Vaccine.
Market Segmentation

Scope of Disease Control and Prevention Vaccine - Market Report

Report Metric Details
Report Name Disease Control and Prevention Vaccine - Market
Forecasted market size in 2030 US$ 84190 million
CAGR 10.4%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GSK, Merck & Co., Inc, Pfizer, Sanofi, AstraZeneca PLC, Sinovac Biotech Ltd, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd, Daiichi Sankyo, Abbott Laboratories, Bharat Biotech International, Bavarian Nordic A/S, CSL Limited, Emergent BioSolutions Inc, Inovio Pharmaceuticals Inc, Johnson & Johnson, Mitsubishi Tanabe Pharma Corporation, Novavax Inc, Panacea Biotec Ltd, Takeda Pharmaceutical Company Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Disease Control and Prevention Vaccine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Disease Control and Prevention Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Disease Control and Prevention Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Disease Control and Prevention Vaccine - Market size in 2030?

Ans: The Disease Control and Prevention Vaccine - Market size in 2030 will be US$ 84190 million.

Who are the main players in the Disease Control and Prevention Vaccine - Market report?

Ans: The main players in the Disease Control and Prevention Vaccine - Market are GSK, Merck & Co., Inc, Pfizer, Sanofi, AstraZeneca PLC, Sinovac Biotech Ltd, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd, Daiichi Sankyo, Abbott Laboratories, Bharat Biotech International, Bavarian Nordic A/S, CSL Limited, Emergent BioSolutions Inc, Inovio Pharmaceuticals Inc, Johnson & Johnson, Mitsubishi Tanabe Pharma Corporation, Novavax Inc, Panacea Biotec Ltd, Takeda Pharmaceutical Company Limited

What are the Application segmentation covered in the Disease Control and Prevention Vaccine - Market report?

Ans: The Applications covered in the Disease Control and Prevention Vaccine - Market report are Pediatric Vaccine, Adult Vaccine

What are the Type segmentation covered in the Disease Control and Prevention Vaccine - Market report?

Ans: The Types covered in the Disease Control and Prevention Vaccine - Market report are Live-Attenuated, Inactivated, Recombinant Sub Unit and Toxoid

Recommended Reports

Vaccines Market Trends

Vaccine Packaging Chain

Special Disease Vaccines

1 Market Overview
1.1 Disease Control and Prevention Vaccine Product Introduction
1.2 Global Disease Control and Prevention Vaccine Market Size Forecast
1.3 Disease Control and Prevention Vaccine Market Trends & Drivers
1.3.1 Disease Control and Prevention Vaccine Industry Trends
1.3.2 Disease Control and Prevention Vaccine Market Drivers & Opportunity
1.3.3 Disease Control and Prevention Vaccine Market Challenges
1.3.4 Disease Control and Prevention Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Disease Control and Prevention Vaccine Players Revenue Ranking (2023)
2.2 Global Disease Control and Prevention Vaccine Revenue by Company (2019-2024)
2.3 Key Companies Disease Control and Prevention Vaccine Manufacturing Base Distribution and Headquarters
2.4 Key Companies Disease Control and Prevention Vaccine Product Offered
2.5 Key Companies Time to Begin Mass Production of Disease Control and Prevention Vaccine
2.6 Disease Control and Prevention Vaccine Market Competitive Analysis
2.6.1 Disease Control and Prevention Vaccine Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Disease Control and Prevention Vaccine Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Live-Attenuated
3.1.2 Inactivated
3.1.3 Recombinant Sub Unit and Toxoid
3.2 Global Disease Control and Prevention Vaccine Sales Value by Type
3.2.1 Global Disease Control and Prevention Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Disease Control and Prevention Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Disease Control and Prevention Vaccine Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pediatric Vaccine
4.1.2 Adult Vaccine
4.2 Global Disease Control and Prevention Vaccine Sales Value by Application
4.2.1 Global Disease Control and Prevention Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Disease Control and Prevention Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Disease Control and Prevention Vaccine Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Disease Control and Prevention Vaccine Sales Value by Region
5.1.1 Global Disease Control and Prevention Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Disease Control and Prevention Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Disease Control and Prevention Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Disease Control and Prevention Vaccine Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Disease Control and Prevention Vaccine Sales Value, 2019-2030
5.2.2 North America Disease Control and Prevention Vaccine Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Disease Control and Prevention Vaccine Sales Value, 2019-2030
5.3.2 Europe Disease Control and Prevention Vaccine Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Disease Control and Prevention Vaccine Sales Value, 2019-2030
5.4.2 Asia Pacific Disease Control and Prevention Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Disease Control and Prevention Vaccine Sales Value, 2019-2030
5.5.2 South America Disease Control and Prevention Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Disease Control and Prevention Vaccine Sales Value, 2019-2030
5.6.2 Middle East & Africa Disease Control and Prevention Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Disease Control and Prevention Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Disease Control and Prevention Vaccine Sales Value
6.3 United States
6.3.1 United States Disease Control and Prevention Vaccine Sales Value, 2019-2030
6.3.2 United States Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Disease Control and Prevention Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Disease Control and Prevention Vaccine Sales Value, 2019-2030
6.4.2 Europe Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Disease Control and Prevention Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Disease Control and Prevention Vaccine Sales Value, 2019-2030
6.5.2 China Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Disease Control and Prevention Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Disease Control and Prevention Vaccine Sales Value, 2019-2030
6.6.2 Japan Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Disease Control and Prevention Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Disease Control and Prevention Vaccine Sales Value, 2019-2030
6.7.2 South Korea Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Disease Control and Prevention Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Disease Control and Prevention Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Disease Control and Prevention Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Disease Control and Prevention Vaccine Sales Value, 2019-2030
6.9.2 India Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Disease Control and Prevention Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GSK
7.1.1 GSK Profile
7.1.2 GSK Main Business
7.1.3 GSK Disease Control and Prevention Vaccine Products, Services and Solutions
7.1.4 GSK Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.1.5 GSK Recent Developments
7.2 Merck & Co., Inc
7.2.1 Merck & Co., Inc Profile
7.2.2 Merck & Co., Inc Main Business
7.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Products, Services and Solutions
7.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.2.5 Merck & Co., Inc Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer Disease Control and Prevention Vaccine Products, Services and Solutions
7.3.4 Pfizer Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.3.5 Sanofi Recent Developments
7.4 Sanofi
7.4.1 Sanofi Profile
7.4.2 Sanofi Main Business
7.4.3 Sanofi Disease Control and Prevention Vaccine Products, Services and Solutions
7.4.4 Sanofi Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.4.5 Sanofi Recent Developments
7.5 AstraZeneca PLC
7.5.1 AstraZeneca PLC Profile
7.5.2 AstraZeneca PLC Main Business
7.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Products, Services and Solutions
7.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.5.5 AstraZeneca PLC Recent Developments
7.6 Sinovac Biotech Ltd
7.6.1 Sinovac Biotech Ltd Profile
7.6.2 Sinovac Biotech Ltd Main Business
7.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
7.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.6.5 Sinovac Biotech Ltd Recent Developments
7.7 Astellas Pharma Inc
7.7.1 Astellas Pharma Inc Profile
7.7.2 Astellas Pharma Inc Main Business
7.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Products, Services and Solutions
7.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.7.5 Astellas Pharma Inc Recent Developments
7.8 Serum Institute of India Pvt. Ltd
7.8.1 Serum Institute of India Pvt. Ltd Profile
7.8.2 Serum Institute of India Pvt. Ltd Main Business
7.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
7.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.8.5 Serum Institute of India Pvt. Ltd Recent Developments
7.9 Daiichi Sankyo
7.9.1 Daiichi Sankyo Profile
7.9.2 Daiichi Sankyo Main Business
7.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Products, Services and Solutions
7.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.9.5 Daiichi Sankyo Recent Developments
7.10 Abbott Laboratories
7.10.1 Abbott Laboratories Profile
7.10.2 Abbott Laboratories Main Business
7.10.3 Abbott Laboratories Disease Control and Prevention Vaccine Products, Services and Solutions
7.10.4 Abbott Laboratories Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.10.5 Abbott Laboratories Recent Developments
7.11 Bharat Biotech International
7.11.1 Bharat Biotech International Profile
7.11.2 Bharat Biotech International Main Business
7.11.3 Bharat Biotech International Disease Control and Prevention Vaccine Products, Services and Solutions
7.11.4 Bharat Biotech International Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.11.5 Bharat Biotech International Recent Developments
7.12 Bavarian Nordic A/S
7.12.1 Bavarian Nordic A/S Profile
7.12.2 Bavarian Nordic A/S Main Business
7.12.3 Bavarian Nordic A/S Disease Control and Prevention Vaccine Products, Services and Solutions
7.12.4 Bavarian Nordic A/S Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.12.5 Bavarian Nordic A/S Recent Developments
7.13 CSL Limited
7.13.1 CSL Limited Profile
7.13.2 CSL Limited Main Business
7.13.3 CSL Limited Disease Control and Prevention Vaccine Products, Services and Solutions
7.13.4 CSL Limited Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.13.5 CSL Limited Recent Developments
7.14 Emergent BioSolutions Inc
7.14.1 Emergent BioSolutions Inc Profile
7.14.2 Emergent BioSolutions Inc Main Business
7.14.3 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Products, Services and Solutions
7.14.4 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.14.5 Emergent BioSolutions Inc Recent Developments
7.15 Inovio Pharmaceuticals Inc
7.15.1 Inovio Pharmaceuticals Inc Profile
7.15.2 Inovio Pharmaceuticals Inc Main Business
7.15.3 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Products, Services and Solutions
7.15.4 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.15.5 Inovio Pharmaceuticals Inc Recent Developments
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Profile
7.16.2 Johnson & Johnson Main Business
7.16.3 Johnson & Johnson Disease Control and Prevention Vaccine Products, Services and Solutions
7.16.4 Johnson & Johnson Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.16.5 Johnson & Johnson Recent Developments
7.17 Mitsubishi Tanabe Pharma Corporation
7.17.1 Mitsubishi Tanabe Pharma Corporation Profile
7.17.2 Mitsubishi Tanabe Pharma Corporation Main Business
7.17.3 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Products, Services and Solutions
7.17.4 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.17.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
7.18 Novavax Inc
7.18.1 Novavax Inc Profile
7.18.2 Novavax Inc Main Business
7.18.3 Novavax Inc Disease Control and Prevention Vaccine Products, Services and Solutions
7.18.4 Novavax Inc Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.18.5 Novavax Inc Recent Developments
7.19 Panacea Biotec Ltd
7.19.1 Panacea Biotec Ltd Profile
7.19.2 Panacea Biotec Ltd Main Business
7.19.3 Panacea Biotec Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
7.19.4 Panacea Biotec Ltd Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.19.5 Panacea Biotec Ltd Recent Developments
7.20 Takeda Pharmaceutical Company Limited
7.20.1 Takeda Pharmaceutical Company Limited Profile
7.20.2 Takeda Pharmaceutical Company Limited Main Business
7.20.3 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Products, Services and Solutions
7.20.4 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Revenue (US$ Million) & (2019-2024)
7.20.5 Takeda Pharmaceutical Company Limited Recent Developments
8 Industry Chain Analysis
8.1 Disease Control and Prevention Vaccine Industrial Chain
8.2 Disease Control and Prevention Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Disease Control and Prevention Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Disease Control and Prevention Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Disease Control and Prevention Vaccine Market Trends
    Table 2. Disease Control and Prevention Vaccine Market Drivers & Opportunity
    Table 3. Disease Control and Prevention Vaccine Market Challenges
    Table 4. Disease Control and Prevention Vaccine Market Restraints
    Table 5. Global Disease Control and Prevention Vaccine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Disease Control and Prevention Vaccine Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Disease Control and Prevention Vaccine Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Disease Control and Prevention Vaccine Product Type
    Table 9. Key Companies Time to Begin Mass Production of Disease Control and Prevention Vaccine
    Table 10. Global Disease Control and Prevention Vaccine Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Disease Control and Prevention Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Disease Control and Prevention Vaccine Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Disease Control and Prevention Vaccine Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Disease Control and Prevention Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Disease Control and Prevention Vaccine Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Disease Control and Prevention Vaccine Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Disease Control and Prevention Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Disease Control and Prevention Vaccine Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Disease Control and Prevention Vaccine Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Disease Control and Prevention Vaccine Sales Value by Region (2019-2024) & (%)
    Table 27. Global Disease Control and Prevention Vaccine Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Disease Control and Prevention Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Disease Control and Prevention Vaccine Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Disease Control and Prevention Vaccine Sales Value, (2025-2030) & (US$ Million)
    Table 31. GSK Basic Information List
    Table 32. GSK Description and Business Overview
    Table 33. GSK Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of GSK (2019-2024)
    Table 35. GSK Recent Developments
    Table 36. Merck & Co., Inc Basic Information List
    Table 37. Merck & Co., Inc Description and Business Overview
    Table 38. Merck & Co., Inc Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Merck & Co., Inc (2019-2024)
    Table 40. Merck & Co., Inc Recent Developments
    Table 41. Pfizer Basic Information List
    Table 42. Pfizer Description and Business Overview
    Table 43. Pfizer Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Pfizer (2019-2024)
    Table 45. Pfizer Recent Developments
    Table 46. Sanofi Basic Information List
    Table 47. Sanofi Description and Business Overview
    Table 48. Sanofi Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Sanofi (2019-2024)
    Table 50. Sanofi Recent Developments
    Table 51. AstraZeneca PLC Basic Information List
    Table 52. AstraZeneca PLC Description and Business Overview
    Table 53. AstraZeneca PLC Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of AstraZeneca PLC (2019-2024)
    Table 55. AstraZeneca PLC Recent Developments
    Table 56. Sinovac Biotech Ltd Basic Information List
    Table 57. Sinovac Biotech Ltd Description and Business Overview
    Table 58. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Sinovac Biotech Ltd (2019-2024)
    Table 60. Sinovac Biotech Ltd Recent Developments
    Table 61. Astellas Pharma Inc Basic Information List
    Table 62. Astellas Pharma Inc Description and Business Overview
    Table 63. Astellas Pharma Inc Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Astellas Pharma Inc (2019-2024)
    Table 65. Astellas Pharma Inc Recent Developments
    Table 66. Serum Institute of India Pvt. Ltd Basic Information List
    Table 67. Serum Institute of India Pvt. Ltd Description and Business Overview
    Table 68. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Serum Institute of India Pvt. Ltd (2019-2024)
    Table 70. Serum Institute of India Pvt. Ltd Recent Developments
    Table 71. Daiichi Sankyo Basic Information List
    Table 72. Daiichi Sankyo Description and Business Overview
    Table 73. Daiichi Sankyo Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Daiichi Sankyo (2019-2024)
    Table 75. Daiichi Sankyo Recent Developments
    Table 76. Abbott Laboratories Basic Information List
    Table 77. Abbott Laboratories Description and Business Overview
    Table 78. Abbott Laboratories Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Abbott Laboratories (2019-2024)
    Table 80. Abbott Laboratories Recent Developments
    Table 81. Bharat Biotech International Basic Information List
    Table 82. Bharat Biotech International Description and Business Overview
    Table 83. Bharat Biotech International Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Bharat Biotech International (2019-2024)
    Table 85. Bharat Biotech International Recent Developments
    Table 86. Bavarian Nordic A/S Basic Information List
    Table 87. Bavarian Nordic A/S Description and Business Overview
    Table 88. Bavarian Nordic A/S Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Bavarian Nordic A/S (2019-2024)
    Table 90. Bavarian Nordic A/S Recent Developments
    Table 91. CSL Limited Basic Information List
    Table 92. CSL Limited Description and Business Overview
    Table 93. CSL Limited Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of CSL Limited (2019-2024)
    Table 95. CSL Limited Recent Developments
    Table 96. Emergent BioSolutions Inc Basic Information List
    Table 97. Emergent BioSolutions Inc Description and Business Overview
    Table 98. Emergent BioSolutions Inc Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Emergent BioSolutions Inc (2019-2024)
    Table 100. Emergent BioSolutions Inc Recent Developments
    Table 101. Inovio Pharmaceuticals Inc Basic Information List
    Table 102. Inovio Pharmaceuticals Inc Description and Business Overview
    Table 103. Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Inovio Pharmaceuticals Inc (2019-2024)
    Table 105. Inovio Pharmaceuticals Inc Recent Developments
    Table 106. Johnson & Johnson Basic Information List
    Table 107. Johnson & Johnson Description and Business Overview
    Table 108. Johnson & Johnson Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Johnson & Johnson (2019-2024)
    Table 110. Johnson & Johnson Recent Developments
    Table 111. Mitsubishi Tanabe Pharma Corporation Basic Information List
    Table 112. Mitsubishi Tanabe Pharma Corporation Description and Business Overview
    Table 113. Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Mitsubishi Tanabe Pharma Corporation (2019-2024)
    Table 115. Mitsubishi Tanabe Pharma Corporation Recent Developments
    Table 116. Novavax Inc Basic Information List
    Table 117. Novavax Inc Description and Business Overview
    Table 118. Novavax Inc Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Novavax Inc (2019-2024)
    Table 120. Novavax Inc Recent Developments
    Table 121. Panacea Biotec Ltd Basic Information List
    Table 122. Panacea Biotec Ltd Description and Business Overview
    Table 123. Panacea Biotec Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Panacea Biotec Ltd (2019-2024)
    Table 125. Panacea Biotec Ltd Recent Developments
    Table 126. Takeda Pharmaceutical Company Limited Basic Information List
    Table 127. Takeda Pharmaceutical Company Limited Description and Business Overview
    Table 128. Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Takeda Pharmaceutical Company Limited (2019-2024)
    Table 130. Takeda Pharmaceutical Company Limited Recent Developments
    Table 131. Key Raw Materials Lists
    Table 132. Raw Materials Key Suppliers Lists
    Table 133. Disease Control and Prevention Vaccine Downstream Customers
    Table 134. Disease Control and Prevention Vaccine Distributors List
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
    Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Disease Control and Prevention Vaccine Product Picture
    Figure 2. Global Disease Control and Prevention Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Disease Control and Prevention Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Disease Control and Prevention Vaccine Report Years Considered
    Figure 5. Global Disease Control and Prevention Vaccine Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Disease Control and Prevention Vaccine Revenue in 2023
    Figure 7. Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Live-Attenuated Picture
    Figure 9. Inactivated Picture
    Figure 10. Recombinant Sub Unit and Toxoid Picture
    Figure 11. Global Disease Control and Prevention Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Disease Control and Prevention Vaccine Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Pediatric Vaccine
    Figure 14. Product Picture of Adult Vaccine
    Figure 15. Global Disease Control and Prevention Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Disease Control and Prevention Vaccine Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Disease Control and Prevention Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Disease Control and Prevention Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Disease Control and Prevention Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Disease Control and Prevention Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Disease Control and Prevention Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Disease Control and Prevention Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Disease Control and Prevention Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Disease Control and Prevention Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Disease Control and Prevention Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Disease Control and Prevention Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Disease Control and Prevention Vaccine Sales Value (%), (2019-2030)
    Figure 28. United States Disease Control and Prevention Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Disease Control and Prevention Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Disease Control and Prevention Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Disease Control and Prevention Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Disease Control and Prevention Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Disease Control and Prevention Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Disease Control and Prevention Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Disease Control and Prevention Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Disease Control and Prevention Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Disease Control and Prevention Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Disease Control and Prevention Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Disease Control and Prevention Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Disease Control and Prevention Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Disease Control and Prevention Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Disease Control and Prevention Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 49. Disease Control and Prevention Vaccine Industrial Chain
    Figure 50. Disease Control and Prevention Vaccine Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India